Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.58ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.58ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.58ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.58NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.75ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.75ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.75ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.75NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.411ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.411ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.411ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.411NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.217ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.217ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.217ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.217NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.35ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.35ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.35ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.35NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.17 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.17 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.17 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.17 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17890.7US
B.1.1.41ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.41ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.41ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.41NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.527ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.527ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.527ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.527NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
C.18ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
C.18ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.18NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.500ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.500ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.500ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.500NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.147ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.147ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.147ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.147NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.487ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.487ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.487ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.487NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.68ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.68ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used